Related Experiment Video
Updated: Apr 27, 2026
Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
Mutational analysis of primary central nervous system lymphoma
Aurélie Bruno1, Blandine Boisselier2, Karim Labreche1
1Sorbonne Universités, UPMC Univ Paris 06, UM 75, ICM, F-75013, Paris, France. Institut National de la Santé et de la Recherche Médicale, U 1127, ICM, F-75013, Paris, France. Centre National de la Recherche Scientifique, UMR 7225, ICM, F-75013, Paris, France. ICM, F-75013, Paris, France.
Genomic analysis of primary central nervous system lymphoma (PCNSL) reveals significant genetic heterogeneity. Mutations in key pathways like NFKB and B cell differentiation suggest shared mechanisms with other lymphomas.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Primary central nervous system lymphoma (PCNSL) is a rare malignancy with poorly understood genomic underpinnings.
- Investigating the genetic landscape of PCNSL is crucial for understanding its tumorigenesis and identifying therapeutic targets.
Purpose of the Study:
- To elucidate the mutational profile of PCNSL.
- To identify recurrently mutated genes and pathways involved in PCNSL development.
- To compare the PCNSL mutational landscape with other lymphoma subtypes.
Main Methods:
- High-throughput exome sequencing of nine paired tumor and germline DNA samples from PCNSL patients.
- Focused resequencing of selected genes in an additional 28 PCNSL tumors.
- Analysis of somatic mutations in 37 genes, including those in NFKB, B cell differentiation, and cell cycle control pathways.
Main Results:
- Recurrent somatic mutations were identified in 37 genes.
- High mutation rates were observed for MYD88 (38%), CD79B (30%), PIM1 (22%), TBL1XR1 (19%), ETV6 (16%), IRF4 (14%), IRF2BP2 (11%), and EBF1 (11%).
- PCNSL exhibits genetic heterogeneity and mutational patterns similar to the activated B-cell (ABC) subtype of extracerebral diffuse large B-cell lymphomas.
Conclusions:
- The study provides novel insights into the genetic landscape of PCNSL.
- Identified mutations highlight potential therapeutic targets for PCNSL.
- Shared mutational patterns suggest common biological mechanisms between PCNSL and ABC-DLBCL.
